Latest debt-to-equity ratio
Beam Therapeutics Debt-to-equity ratio
Direct answer
Beam Therapeutics's debt-to-equity ratio is 23.17%.
The verified market snapshot reports 23.17%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 3, 2026.
Get free Beam Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Debt-to-equity ratio
- 23.17%
Explore related company data
View Beam Therapeutics's market capitalizationView Beam Therapeutics's price-to-book ratioView Beam Therapeutics's return on equityView Beam Therapeutics's 52-week price rangeView Beam Therapeutics's revenue growthView Beam Therapeutics's profit marginView all Beam Therapeutics key metricsReturn to Beam Therapeutics profile